Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 0.13%1.86B | ---- | 1.35%4.07B | ---- | -11.82%1.86B | ---- | -2.09%4.01B | ---- | -3.83%2.11B |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | 48.72%-26.89M | ---- | 11.33%-128.58M | ---- | 24.73%-52.44M | ---- | -19.25%-145.01M | ---- | 2.83%-69.68M |
| Impairment and provisions: | ---- | -55.23%37.18M | ---- | -24.99%346.22M | ---- | 10.11%83.05M | ---- | -17.15%461.56M | ---- | -31.04%75.42M |
| -Other impairments and provisions | ---- | -59.85%35.92M | ---- | -27.33%324.11M | ---- | 6,308.99%89.48M | ---- | -24.96%445.97M | ---- | -98.67%1.4M |
| Asset sale loss (gain): | ---- | 1,182.25%485.24K | ---- | -66,149.68%-42.2M | ---- | 116.40%37.84K | ---- | 99.78%-63.7K | ---- | 99.14%-230.7K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 1,182.25%485.24K | ---- | -66,149.68%-42.2M | ---- | 116.40%37.84K | ---- | 99.78%-63.7K | ---- | 99.14%-230.7K |
| Depreciation and amortization: | ---- | -0.41%364.56M | ---- | -0.46%755.07M | ---- | 4.08%366.07M | ---- | 10.60%758.58M | ---- | 7.76%351.71M |
| -Amortization of intangible assets | ---- | 19.30%135.99M | ---- | 1.62%232.38M | ---- | 1.12%113.99M | ---- | 8.76%228.68M | ---- | 15.97%112.73M |
| -Other depreciation and amortization | ---- | -17.45%10.29M | ---- | 39.82%33.01M | ---- | -8.24%12.47M | ---- | -56.24%23.61M | ---- | 11.74%13.59M |
| Financial expense | ---- | -10.73%135M | ---- | -61.89%-48.84M | ---- | 296.26%151.22M | ---- | -111.53%-30.17M | ---- | 134.70%38.16M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 12.53%-376.68M | ---- | 70.36%-247.54M | ---- | 27.20%-430.64M | ---- | -832.20%-835.17M | ---- | -195.75%-591.54M |
| Accounts receivable (increase)decrease | ---- | -126.46%-571.72M | ---- | 40.47%-1.51B | ---- | 305.89%2.16B | ---- | 48.28%-2.54B | ---- | 50.96%-1.05B |
| Accounts payable increase (decrease) | ---- | -466.81%-5.91B | ---- | 136.60%2.12B | ---- | 36.05%-1.04B | ---- | -36.68%895.3M | ---- | -820.27%-1.63B |
| Special items of business | ---- | 166.95%81.62M | ---- | 85.96%-73.29M | ---- | -17.87%-121.92M | ---- | -4,786.47%-521.93M | ---- | 92.60%-103.44M |
| Adjustment items of business operations | -210.29%-3.75B | -244.99%-4.49B | -291.90%-4B | 105.79%5.31B | 524.55%3.4B | 503.12%3.09B | 259.28%2.08B | 24.57%2.58B | -333.16%-800.98M | -350.66%-767.67M |
| Net cash from operations | -210.29%-3.75B | -248.20%-4.41B | -291.90%-4B | 154.42%5.24B | 524.55%3.4B | 441.26%2.97B | 259.28%2.08B | -1.16%2.06B | -333.16%-800.98M | 20.17%-871.1M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 444.06%27.75M | 413.62%26.19M | ---- | -34.10%35.38M | -87.59%5.1M | -87.16%5.1M | ---- | 36.50%53.69M | 61.29%41.09M | 108.79%39.72M |
| Sale of fixed assets | -99.54%683.61K | -98.17%174.65K | -80.81%19.48K | 12,086.94%146.46M | 23,822.31%147.94M | 2,361.28%9.54M | -16.37%101.48K | -96.48%1.2M | -98.17%618.41K | -98.95%387.47K |
| Purchase of fixed assets | 46.16%-271.36M | -15.63%-221.59M | -25.43%-98.14M | -26.20%-858.93M | -74.31%-504M | -4.65%-191.63M | 13.88%-78.24M | 3.87%-680.61M | -42.07%-289.14M | -33.03%-183.12M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | --4.19M | --4.19M | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --92.68M | --90.3M | --76.5M |
| Cash on investment | -878.57%-421.52M | -896.56%-419.52M | ---419.33M | -79.75%-195.07M | 48.73%-43.08M | 49.90%-42.1M | ---- | -56.38%-108.52M | -24.25%-84.02M | 95.73%-84.02M |
| Other items in the investment business | 73.63%-441.85M | 373.54%710.28M | 638.34%988.44M | 124.17%285.46M | -537.91%-1.68B | 80.78%-259.66M | -12.49%133.87M | -313.61%-1.18B | -120.14%-262.65M | -86.12%-1.35B |
| Net cash from investment operations | 46.43%-1.11B | 120.13%95.53M | 745.08%470.99M | 67.81%-586.69M | -309.95%-2.07B | 68.39%-474.57M | -23.49%55.73M | -1,107.55%-1.82B | -146.12%-503.8M | 45.90%-1.5B |
| Net cash before financing | -463.74%-4.86B | -272.52%-4.31B | -264.87%-3.53B | 1,875.65%4.65B | 202.33%1.34B | 205.29%2.5B | 273.19%2.14B | -87.81%235.34M | -243.77%-1.3B | 38.64%-2.37B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 3,095.50%4.38B | 313.37%2.9B | --2.19B | -80.89%467.45M | -93.15%136.96M | -69.31%701.89M | ---- | 58.80%2.45B | 52.45%2B | 271.29%2.29B |
| Refund | 95.65%-94.3M | 97.75%-51.27M | 99.91%-1.93M | -60.70%-2.2B | -93.54%-2.17B | -93.95%-2.28B | -128.31%-2.12B | -402.12%-1.37B | -336.41%-1.12B | -1,184.45%-1.17B |
| Dividends paid - financing | -12.41%-2.32B | 14.79%-88.04M | 25.53%-38.22M | 2.59%-2.43B | -7.23%-2.07B | -3.91%-103.32M | ---51.33M | -7.49%-2.49B | 8.91%-1.93B | -232.02%-99.43M |
| Absorb investment income | -77.04%11.25M | -15.82%8.25M | --8.25M | 7,983.33%97M | --49M | --9.8M | ---- | -99.08%1.2M | ---- | ---- |
| Other items of the financing business | 72.90%-14.47M | -10.66%-59.08M | --26.87M | -322.97%-192.55M | -101.00%-53.39M | -34.98%-53.39M | ---- | 96.96%-45.52M | ---26.56M | -126.47%-39.56M |
| Net cash from financing operations | 147.73%1.96B | 257.31%2.71B | 200.78%2.18B | -191.29%-4.26B | -282.26%-4.1B | -277.13%-1.72B | -311.70%-2.17B | 39.54%-1.46B | -4.10%-1.07B | 48.74%973.02M |
| Effect of rate | 304.66%3.7M | 1,238.81%4.96M | 742.04%1.11M | -166.23%-3.69M | -138.58%-1.81M | -103.83%-435.28K | 92.46%-172.83K | -95.83%5.57M | -95.86%4.69M | -80.04%11.36M |
| Net Cash | -4.93%-2.9B | -306.37%-1.6B | -4,540.20%-1.34B | 131.74%389.44M | -16.28%-2.76B | 155.35%774.67M | 86.30%-28.9M | -151.65%-1.23B | -1,839.63%-2.38B | 56.43%-1.4B |
| Begining period cash | 2.41%16.41B | 2.41%16.41B | 2.41%16.41B | -7.08%16.02B | -7.08%16.02B | -7.08%16.02B | -7.08%16.02B | -2.01%17.24B | -2.01%17.24B | -2.01%17.24B |
| Cash at the end | 1.92%13.51B | -11.80%14.81B | -5.79%15.07B | 2.41%16.41B | -10.86%13.25B | 5.94%16.79B | -6.09%15.99B | -7.08%16.02B | -15.45%14.87B | 9.79%15.85B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.